Haibin P. Dai

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Liposome drug delivery strategies: state-of-the-art for combating bacterial biofilms.

Liposome drug delivery strategies: state-of-the-art for combating bacterial biofilms.

Journal: Frontiers in microbiology

Published: June 03, 2026

Tivozanib versus Sorafenib as Subsequent-Line Therapy for Advanced Renal Cell Carcinoma: A Cost-Effectiveness Analysis from a US Healthcare Perspective.

Tivozanib versus Sorafenib as Subsequent-Line Therapy for Advanced Renal Cell Carcinoma: A Cost-Effectiveness Analysis from a US Healthcare Perspective.

Journal: Risk management and healthcare policy

Published: April 25, 2026

Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining.

Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining.

Journal: Frontiers in pharmacology

Published: December 26, 2025

Evaluating the association between intravenous immunoglobulin and thromboembolic events in patients with autoimmune diseases: a retrospective real-world study.

Evaluating the association between intravenous immunoglobulin and thromboembolic events in patients with autoimmune diseases: a retrospective real-world study.

Journal: Frontiers in pharmacology

Published: December 08, 2025

Multicentre development and validation of a risk model integrating immunotherapy and coagulation biomarkers for thrombosis in autoimmune neurological disorders.

Multicentre development and validation of a risk model integrating immunotherapy and coagulation biomarkers for thrombosis in autoimmune neurological disorders.

Journal: International immunopharmacology

Published: November 11, 2025

Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections: protocol for a cluster-randomized controlled trial.

Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections: protocol for a cluster-randomized controlled trial.

Journal: Frontiers in public health

Published: November 08, 2025

Variations in ventricular distribution of polymyxin B following intraventricular administration in patients with central nervous system infections.

Variations in ventricular distribution of polymyxin B following intraventricular administration in patients with central nervous system infections.

Journal: Antimicrobial agents and chemotherapy

Published: November 06, 2025

Recent Advances in Peptide Linkers for Antibody-Drug Conjugates.

Recent Advances in Peptide Linkers for Antibody-Drug Conjugates.

Journal: Journal of medicinal chemistry

Published: September 22, 2025

Myasthenia gravis and community-acquired pneumonia: therapeutic challenges.

Myasthenia gravis and community-acquired pneumonia: therapeutic challenges.

Journal: Frontiers in pharmacology

Published: August 29, 2025

Accurate Identification of Protein Binding Sites for All Drug Modalities Using ALLSites.

Accurate Identification of Protein Binding Sites for All Drug Modalities Using ALLSites.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 26, 2025

Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy.

Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy.

Journal: Drug design, development and therapy

Published: August 14, 2025

M6AREG 2.0: the landscape of m6A-centered crosstalk with diverse epigenetic regulation.

M6AREG 2.0: the landscape of m6A-centered crosstalk with diverse epigenetic regulation.

Journal: Nucleic acids research

Published: August 07, 2025

Showing 1-12 of 106

Last Updated: 09/26/2026